Cargando…
CXCR4 chemokine receptor signaling mediates pain in diabetic neuropathy
BACKGROUND: Painful Diabetic Neuropathy (PDN) is a debilitating syndrome present in a quarter of diabetic patients that has a substantial impact on their quality of life. Despite this significant prevalence and impact, current therapies for PDN are only partially effective. Moreover, the cellular me...
Autores principales: | Menichella, Daniela Maria, Abdelhak, Belmadani, Ren, Dongjun, Shum, Andrew, Frietag, Caroline, Miller, Richard J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078021/ https://www.ncbi.nlm.nih.gov/pubmed/24961298 http://dx.doi.org/10.1186/1744-8069-10-42 |
Ejemplares similares
-
Ganglioside GM3 synthase depletion reverses neuropathic pain and small fiber neuropathy in diet-induced diabetic mice
por: Menichella, Daniela M, et al.
Publicado: (2016) -
Mitochondrial calcium uniporter deletion prevents painful diabetic neuropathy by restoring mitochondrial morphology and dynamics
por: George, Dale S., et al.
Publicado: (2022) -
Agonists for the Chemokine Receptor CXCR4
por: Lefrançois, Marilou, et al.
Publicado: (2011) -
Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5
por: Schmutz, Caroline, et al.
Publicado: (2005) -
The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16
por: Adamski, Vivian, et al.
Publicado: (2017)